Skip to main content

Lonza plans to create new jobs at Stücki Park

| News

Lonza plans to create new jobs at Stücki Park

29.03.2019

Swiss Prime Site is about to create additional office and laboratory space for 1,700 new jobs at Stücki Park in Basel. The chemical specialists Lonza will rent space to hire an additional 250 specialists from 2020.

Stücki Park (img: Florian Lotter)

Stücki Park is being expanded further. Swiss Prime Site has announced in a press release that 190 million Swiss francs will be invested in expanding the existing laboratory and office space. This will see the rental area more than doubled by 33,000 square meters to a total of 60,000 square meters by 2023, thereby creating space for 1,700 new jobs at the site in north Basel.

The chemical specialists Lonza, already an established presence at Stücki Park as anchor tenants, will rent new buildings across a surface area of 8,000 square meters. From the third quarter of 2020, around 250 new specialists will work in the new buildings, “thus further enhancing Basel as a major economic area”, as Prof. Dr. Hanns-Christian Mahler, Head of Lonza Drug Product Services, commented in the press release. “As we continue to grow in Drug Product Services, the new buildings at Stücki Park are ideal for us”, he concluded.

Peter Lehmann, CEO Swiss Prime Site Immobilien, was delighted about Lonza’s expansion, commenting in the press release: “The complete rental of the existing long building and a substantial part of the new building represents a significant milestone for the site, which this project will make considerably more attractive”.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Building the future of healthtech, digital health and techbio in the Basel Area

Meet our Chief Representative USA: with over 30 years in the biotech industry, Kirsten Detrick brings invaluable expertise for companies...
Read More

The power of a persuasive pitch deck

Are you an entrepreneur striving to secure investment for your biotech startup? Start with an effective pitch deck to catch...
Read More

Roche investing an additional 1.2 billion Swiss francs in Basel

Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment...
Read More

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

Do you have a question? We'd like to hear from you.